pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Preclinical
BA-102
Phelan-McDermid Syndrome (22q13.3 Deletion Syndrome)
$XAIR
Beyond Air, Inc.
Preclinical
BA-3142
Head And Neck Cancer
$BCAB
BioAtla, Inc.
BACITRACIN ZINC AND POLYMYXIN B SULFATE
BACITRACIN ZINC AND POLYMYXIN B SULFATE
no indication
BAUSCH AND LOMB
Phase 1
← prev
page 61 of 231
next →
Pain
89
Neurology
1
BAL-0891
Adenocarcinoma Of The Gastroesophageal Junction
Sillajen Biotherapeutics
Preclinical
BAL-200
Anthrax
iNtRON Biotechnology Inc
BALANCED SALT
BALANCED SALT (SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, AND SODIUM CITRATE)
no indication
B BRAUN
Phase 2
BAT-8006
Epithelial Ovarian Cancer
Bio-Thera Solutions Ltd
Phase 2
BAY-3401016
Alport Syndrome
Bayer AG
Phase 2
BB-1701
Human Epidermal Growth Factor Receptor 2 Positive Breast…
Bliss Biopharmaceutical (Hangzhou) Co Ltd
Phase 2
BB-301
Pabparna
Oculopharyngeal Muscular Dystrophy
$BNTC
Benitec Biopharma Inc.
Preclinical
BB-IO
Unspecified Infectious Diseases
BroadenBio Co Ltd
Phase 1
BBI-940
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$BOLD
Boundless Bio, Inc.
Phase 1
BBO-11818
Pancreatic Ductal Adenocarcinoma
$BBOT
BridgeBio Oncology Therapeutics, Inc.
Phase 1
BBO-8520
Metastatic Colorectal Cancer
$BBOT
BridgeBio Oncology Therapeutics, Inc.
Phase 2
BBP-812
Canavan Disease
Aspa Therapeutics Inc
Preclinical
BBS10
no indication
MeiraGTx UK II Ltd
Preclinical
BBT-059
Radiation Toxicity (Radiation Sickness, Acute Radiation S…
Bolder Biotechnology Inc
Phase 2
BBT-207
Non-Small Cell Lung Cancer
Parataxis Korea Inc
Phase 2
BBT-401
Ulcerative Colitis
Parataxis Korea Inc
Phase 2
BBT-877
Idiopathic Pulmonary Fibrosis
Parataxis Korea Inc
Phase 1
BC-3195
Endometrial Cancer
BioCity Biopharma Co Ltd
Preclinical
BCB-276
Pediatric Diffuse Intrinsic Pontine Glioma
BrainChild Bio Inc
Phase 2
BCX-17725
Netherton Syndrome (Bamboo Hair)
$BCRX
BIOCRYST PHARMACEUTICALS INC
Preclinical
BCyIF-1
Solid Tumor
BioCytics
Phase 2
BDTX-4933
Metastatic Colorectal Cancer
Les Laboratoires Servier SAS
Phase 2
BE-101
Hemophilia B (Factor IX Deficiency)
Be Biopharma Inc
Preclinical
BEA-17
Glioblastoma Multiforme (GBM)
Beactica Therapeutics AB
Phase 2
BEAM-201
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$BEAM
Beam Therapeutics Inc.
Phase 2
BEAM-301
Glycogen Storage Disease 1A
$BEAM
Beam Therapeutics Inc.
Phase 2
BEAM-302
Alpha-1 Antitrypsin Deficiency (A1AD)
$BEAM
Beam Therapeutics Inc.